Compare AOS & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AOS | RVTY |
|---|---|---|
| Founded | 1874 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 9.9B |
| IPO Year | N/A | N/A |
| Metric | AOS | RVTY |
|---|---|---|
| Price | $66.26 | $104.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 13 |
| Target Price | $77.57 | ★ $112.92 |
| AVG Volume (30 Days) | 1.4M | ★ 1.7M |
| Earning Date | 10-28-2025 | 10-27-2025 |
| Dividend Yield | ★ 2.18% | 0.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.70 | 1.99 |
| Revenue | ★ $3,830,100,000.00 | $2,813,367,000.00 |
| Revenue This Year | $2.01 | $5.37 |
| Revenue Next Year | $3.59 | $3.07 |
| P/E Ratio | ★ $17.81 | $53.56 |
| Revenue Growth | N/A | ★ 3.37 |
| 52 Week Low | $58.83 | $81.36 |
| 52 Week High | $77.31 | $128.29 |
| Indicator | AOS | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 50.03 | 68.48 |
| Support Level | $62.97 | $89.65 |
| Resistance Level | $66.10 | $106.52 |
| Average True Range (ATR) | 1.28 | 2.79 |
| MACD | 0.36 | 1.32 |
| Stochastic Oscillator | 72.34 | 86.96 |
A.O. Smith manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments: North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for the residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s. However, the firm announced a strategic review of its China operations.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.